A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has ...

The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...

The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic. HealthDay News — A new malaria treatment has been approved for newborns and ...

At the turn of the millennium, a new class of drugs derived from ancient Chinese herbal medicine revolutionized malaria care. Artemisinin's, as they're called, are based on extracts from the sweet ...

This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. (Novartis via AP) (Uncredited) NEW YORK – Researchers on Wednesday ...

Please provide your email address to receive an email when new articles are posted on . Pyronaridine, a common malaria drug, has been used for more than 50 years. The agent could be repurposed to ...

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that.

A drug to treat malaria - the first such pill to get approval in 60 years - has been given the green light by authorities in the United States. The medicine is specifically for the recurring form of ...

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. US Army hypersonic missile ...